Michael J. Welsh serves as Executive at CANCER GENETICS, INC, where they oversee executive responsibilities. Since joining the company, Michael J. Welsh has executed 4 insider transactions totaling $97, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 28, 2017 involved receiving (via award) 2,500 shares valued at $0.
Michael J. Welsh currently holds 12,540 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Welsh has been a net buyer of CGIX stock. They have purchased $97 and sold $0 worth of shares.
Michael J. Welsh's most recent insider trade was on Sep 28, 2017, when they sold 2,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 11, 2016 | CGIX | $0 | Award | 2,500 | $N/A | Discretionary |
| Mar 16, 2016 | CGIX | $97 | Purchase | 40 | $2.42 | Discretionary |